Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -20.80M | -21.07M | -13.64M | -22.94M | -29.92M |
Total Depreciation and Amortization | 173.00K | 173.00K | 153.00K | 140.00K | 133.00K |
Total Amortization of Deferred Charges | 1.05M | 602.00K | 602.00K | 602.00K | 602.00K |
Total Other Non-Cash Items | 2.26M | 1.91M | -5.03M | 5.17M | 13.08M |
Change in Net Operating Assets | -638.00K | -6.32M | -2.89M | -2.90M | -983.00K |
Cash from Operations | -17.95M | -24.71M | -20.80M | -19.93M | -17.09M |
Capital Expenditure | -980.00K | -1.54M | -440.00K | -203.00K | -153.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | 0.00 | -542.00K | -- | -- |
Cash from Investing | -980.00K | -1.54M | -982.00K | -203.00K | -153.00K |
Total Debt Issued | 20.00M | 15.00M | 10.50M | 11.00M | 10.00M |
Total Debt Repaid | -916.00K | -563.00K | -563.00K | -563.00K | -563.00K |
Issuance of Common Stock | 2.12M | 2.23M | 1.79M | 1.79M | 109.00K |
Repurchase of Common Stock | -371.00K | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | 1.00M | 1.00M | 1.00M |
Repurchase of Preferred Stock | -- | -1.00M | -1.00M | -1.00M | -1.00M |
Total Dividends Paid | -2.45M | -1.83M | -- | -- | -- |
Other Financing Activities | 1.82M | 0.00 | 11.74M | 11.74M | 11.74M |
Cash from Financing | 20.20M | 13.83M | 23.47M | 23.97M | 21.28M |
Foreign Exchange rate Adjustments | -5.00K | -5.00K | -5.00K | -5.00K | -3.00K |
Miscellaneous Cash Flow Adjustments | 1.00K | -- | -- | -- | -- |
Net Change in Cash | 1.27M | -12.42M | 1.68M | 3.83M | 4.04M |